Update: Investigation of anthrax associated with intentional exposure and interim public health guidelines, October 2001

Morbidity and Mortality Weekly Report

Volumn 50, Issue 41, 2001, Pages 889-893

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CIPROFLOXACIN;

ADULT; AGED; ANTHRAX; ARTICLE; BACILLUS ANTHRACIS; BACTERIAL SKIN DISEASE; BACTERIAL SPORE; BIOLOGICAL WARFARE; CASE REPORT; FEMALE; HUMAN; INFANT; ISOLATION AND PURIFICATION; MALE; MIDDLE AGED; PRACTICE GUIDELINE; PUBLIC HEALTH SERVICE; RESPIRATORY TRACT INFECTION; UNITED STATES;

ADULT; AGED; ANTHRAX; ANTI-INFECTIVE AGENTS; BACILLUS ANTHRACIS; BIOTERRORISM; CIPROFLOXACIN; FEMALE; FLORIDA; HUMANS; INFANT; MALE; MIDDLE AGED; NEW YORK CITY; PRACTICE GUIDELINES; PUBLIC HEALTH PRACTICE; RESPIRATORY TRACT INFECTIONS; SKIN DISEASES, BACTERIAL; SPORES, BACTERIAL; UNITED STATES;

EID: 0035914370     PISSN: 01492195     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (5)

1. 1.CDC. Ongoing investigation of anthrax - Florida, October 2001. MMWR 2001;50:877.
2. CDC. Human anthrax associated with an epizootic among livestock - North Dakota, 2000. MMWR 2001;50:677-80.
3. Ashford DA, Rotz LD, Perkins BA. Use of anthrax vaccine in the United States: recommendations of the Advisory Committee on Immunization Practice (ACIP). MMWR 2000;49(no. RR-15).
4. Brachman PS. Inhalational anthrax. Ann NY Acad Sci 1980;353:83-93.
5. Brachman PS, Kaufmann A. Anthrax. In: Evans AS, Brachman PS, eds. Bacterial infections of humans. New York, New York: Plenum Medical Book Company, 1998.